Johnny Yin MD

Johnny has 17 years of Biotechnology industry experience. Johnny is a knowledgeable preclinical R&D expert who has seen all stages of antibody drug discovery and development, including GMP manufacturing. Johnny’s specific and extensive experience in antibody target validation and drug discovery, combined with additional experience in pharmacology and translational medicine allows him to effectively evaluate the performance of early stage biologics, elucidate their clinical relevance, and see them evolve into late stage therapeutics in order to add value to the organization's program. Most recently Johnny was with Astellas Pharma US, designing and engineering biochemical and cell biology assays for the purpose of characterizing the performance, behavior, and mechanism of action of antibody-drug conjugates and its subunits